Survival outcomes for Australian women receiving trastuzumab for HER2-positive metastatic breast cancer following (neo)adjuvant trastuzumab: a national population-based observational study (2006–2014)

from Cancer via ola Kala on Inoreader http://ift.tt/2jqkEgg
via IFTTT